FDA Approves Possis Spiroflex® Catheter For Coronary Blood Clot Removal
Wed, 31 Jan 2007 06:00 PM EST
... Possis Medical, Inc. (NASDAQ-NMS: POSS) a developer, manufacturer and distributor of pioneering medical devices used in endovascular procedures, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market its AngioJet® Spiroflex® rapid exchange catheter to remove blood clots (thrombus) from coronary arteries. [click link for full article] ...
Related Topics
- Coronary Artery Disease
- Coronary Artery Diseases
- Coronary Heart Disease
- Blood Disorders
- Coronary Disease
- Blood Clot
- Blood clot formation
- Angioplasty
- Blood clot in the vein of the spleen
- Coronary Angioplasty
- Blood clots or an infected clot that travels other organs, causing infection and severe damage
- Blood/Blood Transfusion
- Blood Transfusion
- Blood Donation
- Blood in Urine
- Acute Coronary Syndrome
- Blood Gases
- Blood Culture
- Low Blood Pressure
- Thrombophlebitis

Not Signed In -

